Skip to main content
logo
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
47.25
-2.79 (-5.58%)
Nov 10, 2026, 10:41 AM EST - Market open

CRISPR Therapeutics AG Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Net Income
-111.44-91.15-122.93-130.61-106.44-208.55-136-37.31-85.94-126.41-116.5989.35-112.15-77.74-53.07-110.58-174.55-185.83-179.22-141.25
Depreciation & Amortization
4.244.284.325.664.434.654.744.844.744.854.834.94.934.965.055.855.027.276.046.26
Other Amortization
0.740.85------------------
Asset Writedown & Restructuring Costs
-0.832.47---96.25------11.5------
Stock-Based Compensation
17.9617.3216.3218.0816.617.6120.2121.9521.5423.6719.4118.4219.9721.7720.8822.8124.5524.8525.7525.77
Other Operating Activities
-2.51-13.568.8-8.31-10.14-7.332.25-15.16-6.9-8.18-8.39-4.77-6.16-4.65-0.970.222.583.576.14.69
Change in Accounts Receivable
------25-25--200-20070-70-0.050.020.080.16-0.15
Change in Accounts Payable
20.62-5.31-13.024.4212.18-14.743-7.85-38.169.289.44-9.19-24.69-11.5825.21-31.127.969.92-1.6222.78
Change in Unearned Revenue
-12.64-0.16-0.432.15-0.83-0.89-0.82-0.64-0.54-0.27-0.5-1.217---0.250.25-0.25-0.76-0
Change in Other Net Operating Assets
-5.821.76-1.9716.06-0.43-0.92-12.339.13-1.661.481.556.420.262.511.69-0.338.96-1.568.31-4.13
Operating Cash Flow
-89.68-83.5-108.9-92.55-84.63-113.88-53.95-50.03-106.91-95.58109.75-96.07-39.86-133.258.8-113.33-105.22-141.96-135.24-86.04
Operating Cash Flow Growth (YoY)
----------1147.32%---------

Investing Activities

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Capital Expenditures
-0.41-0.65-0.5-0.52-0.07-0.12-0.21-0.25-0.22-0.71-0.72-0.74-2.12-3.56-3.06-6.19-6.02-9.63-15.35-9.18
Sale (Purchase) of Intangibles
0.83-2.47----25-------1-1.5------
Investment in Securities
-14.5-52.54-410.2437.72-119.1595.09-19.55106.08-161.39-126.2-97.08-80.72124.47221.98120.89-169.3493.48-46.44-99.170.47
Investing Cash Flow
-14.09-55.66-410.7437.2-119.2369.98-19.76105.83-161.6-126.91-97.8-81.45121.35216.92117.83-175.5387.46-56.07-114.52-8.72

Financing Activities

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Long-Term Debt Issued
--600-----------------
Total Debt Issued
--600-----------------
Net Debt Issued (Repaid)
--600-----------------
Issuance of Common Stock
4.458.36.16116.41296.772.2610.5916.889.64-305.9338.941.5616.775.42.4815.1110.3510.656.3
Repurchase of Common Stock
----------0.47----------
Other Financing Activities
--1.12-14.25-----------------
Financing Cash Flow
4.457.18591.91116.41296.772.2610.5916.889.64-0.47305.9338.941.5616.775.42.4815.1110.3510.656.3

Net Cash Flow

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Foreign Exchange Rate Adjustments
0.010.01-0.030-0.030.080.04-0.090.080-0.010.06-0.050.030.030.12-0.1-0.07-0.030
Miscellaneous Cash Flow Adjustments
------------0--------
Net Cash Flow
-99.31-131.9772.2461.0692.88-41.57-63.0772.59-258.8-222.95317.88-138.5383100.47132.06-286.27-2.74-187.74-239.13-88.45

Free Cash Flow

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
-90.1-84.15-109.4-93.07-84.71-114-54.15-50.29-107.13-96.29109.03-96.81-41.97-136.85.74-119.52-111.24-151.59-150.59-95.22
Free Cash Flow Growth (YoY)
----------1799.49%---------
Free Cash Flow Margin
-711.17%-826.50%-7503.50%-10771.99%-9528.46%-12779.93%-6260.46%-140.89%-17796.01%-18624.57%21633.13%-48.12%--195.43%5.74%-1991983.33%-118335.11%-95940.51%-16020.11%-738.20%
Free Cash Flow Per Share
-0.93-0.87-1.14-0.98-0.93-1.31-0.63-0.59-1.26-1.131.33-1.19-0.53-1.730.07-1.53-1.43-1.96-1.95-1.24
Levered Free Cash Flow
-47.72-56.69-70.87-40.13-48.16-101.74-15.6-41.33-80.67-55.64148.37-130.62-12.04-117.5921.29-95.08-57.54-85.34-99.62-43.24
Unlevered Free Cash Flow
-48.45-57.54-70.87-40.13-48.16-101.74-15.6-41.33-80.67-55.64148.37-130.62-12.04-117.5921.29-95.08-57.54-85.34-99.62-40.86

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Change in Working Capital
2.15-3.7-15.4122.6410.91-16.5154.85-24.35-40.3610.49210.49-203.9752.56-79.0836.91-31.6237.198.196.118.49
SEC Filings: 10-K · 10-Q